NBC Securities’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.07K Buy
4,400
+1,000
+29% +$1.37K ﹤0.01% 2033
2026
Q1
$3.1K Hold
3,400
﹤0.01% 2233
2025
Q4
$3.84K Hold
3,400
﹤0.01% 2266
2025
Q3
$4.86K Hold
3,400
﹤0.01% 2218
2025
Q2
$4K Hold
3,400
﹤0.01% 2165
2025
Q1
$3K Buy
3,400
+3,394
+56,567% +$4.31K ﹤0.01% 1980
2024
Q4
$8 Sell
6
-6,066
-100% -$8.71K ﹤0.01% 1215
2024
Q3
$9K Buy
6,072
+2,672
+79% +$4.96K ﹤0.01% 1773
2024
Q2
$5K Hold
3,400
﹤0.01% 1855
2024
Q1
$3K Hold
3,400
﹤0.01% 1953
2023
Q4
$3K Hold
3,400
﹤0.01% 1964
2023
Q3
$4K Buy
+3,400
New +$4.81K ﹤0.01% 1911

Other funds holding NNVC

NBC Securities's NNVC Position: Q2 2026 in Review

NBC Securities increased its NanoViricides (NNVC) stake by 29% in Q2 2026, buying an estimated $1.37K and bringing the position to 4,400 shares worth $6.07K. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

NBC Securities first reported a position in NNVC in Q3 2023 and has held it in 12 quarters since. The position peaked at $9K in Q3 2024. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • NBC Securities held 4,400 shares of NanoViricides worth $6.07K as of Q2 2026.
  • NBC Securities bought 1,000 NanoViricides shares in Q2 2026, an estimated $1.37K.
  • NanoViricides made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2033 holding.
  • NBC Securities first reported a position in NanoViricides in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's NanoViricides position peaked at $9K in Q3 2024.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.